Singapore’s HES Energy Systems Pushes Forward on Long Range Hydrogen-Electric Flight, Joins Forces with French Aerospace & Energy Tech Developers to Form Complete Value Chain
HES Energy Systems, the leading Fuel Cell Systems developer from Singapore has formed an Alliance with three French Clean Energy and Aerospace Tech companies. Named FLY-HY, the group’s mission is to begin addressing the global market as a unified value chain, ranging from hydrogen refueling systems to energy storage and power conversion, and cooperate with leading designers of electric aircraft.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180205006042/en/
Singaporean Energy Tech company HES Energy Systems powers French air-droppable drone by Airborne Concept using a 10h hydrogen on demand fuel cell system (Photo: Business Wire)
The FLY-HY alliance will officially make its debut at the 2018 Singapore Airshow at H3 Dynamics (booth C18), HES’ parent company.
HES Energy Systems develops small-scale battery alternatives based on its special breed of ultra-light hydrogen fuel cell systems capable of storing energy at over 700Wh/kg, 3 to 4 times the electrical energy per weight of lithium batteries. “The hydrogen molecule is the lightest energy carrier in the universe. Meanwhile most of today’s electric aircraft research has been focused on work-arounds using much heavier lithium batteries. We see a clear opportunity to contribute to the exciting world of electric flight” said Taras Wankewycz, Founder & CEO of HES and parent company H3 Dynamics.
Thinking big yet starting small, HES started out increasing the flight endurance of small electric powered unmanned aircraft (UAVs) or drones, using its special lightweight fuel cell and hydrogen storage technology. The company has been working closely with numerous tier-one electric-UAV manufacturers and believes a scaled-up version of its products could also improve the flight range for personal mobility aerial vehicles as well as electric-powered passenger aircraft.
2018 was proclaimed by Singapore Prime Minister Lee Hsien Loong and Former French President François Hollande as the Year of Innovation between France and Singapore, highlighting Cleantech as one of the key focus areas. In June 2017, Singapore’s HES’s parent company H3 Dynamics established its European HQ in Paris, a decision warmly welcomed by President Emmanuel Macron and his government.
After operating for some time locally in France, H3 Dynamics decided to combine its “Made in Singapore” aerospace-grade hydrogen fuel cell capability with complementary “Made in France” high tech solutions, including novel electric UAV platforms (Toulouse-based Airborne Concept, backed by Airbus), hydrogen gas storage devices (AD-VENTA), and innovative hydrogen generating electrolyzers (ERGOSUP, backed by Air Liquide) which is now adapting its innovative systems to refueling small HES-powered hydrogen drones.
HES Energy Systems and ERGOSUP are also working in partnership with DELAIR, another French drone tech company, on project HYDRONE, a laureate of a French National Call for Projects “Territoires Hydrogène”. The national project aims to deploy five hydrogen drone and refueling systems capable of covering the entire French territory during 2018 and 2019.
This initiative also follows the launch of the Hydrogen Council in 2017, involving a number of high-profile companies including Air Liquide, Alstom, AngloAmerican, BMW Group, Daimler, Engie, Honda, Hyundai, Shell, Linde, Total, Toyota, Audi, General Motors, Statoil & Iwatani, working together to promote a new hydrogen economy and society.
HES Energy Systems (Singapore) www.hes.sg
HES Energy Systems is a global leader in developing ultralight fuel cells and hydrogen energy storage systems for aerospace and other weight sensitive applications. Hired by tier-one UAV manufacturers, and leading aerospace institutes around the world, the company uses a variety of hydrogen storage approaches, including gaseous compressed, chemical hydrides and reforming. HES was acquired in 2015 by H3 Dynamics Group, which is developing off-grid field robotics and AI-enabled data services.
ERGOSUP (France) http://www.ergosup.com/en/
ERGOSUP has developed an innovative hydrogen production process based on zinc electrochemistry. Its first product is a 350 bar hydrogen generator supplying 1 to 5 kg of hydrogen per day. ERGOSUP is planning to launch a simple and cost competitive H2 generator capable of filling up “plug and play” composite cylinders, allowing hydrogen to be supplied for a single drone or a fleet. The company is backed by ALIAD (Air Liquide Venture Capital), DEMETER PARTNERS, GO CAPITAL and ARKEA Capital Investment.
Airborne Concept (France) http://www.airborne-concept.com
Airborne Concept is based in Toulouse and specializes in the design, development and construction of innovative drones. Two patented UAVs, the world's first air-droppable drone and a VTOL are the pride of the Airborne Concept teams, made up of former flight crew members from the French Air Force and engineers graduated from aeronautical engineering schools. Airborne Concept is developing air-droppable drones for Special Forces and its Up-Start drone for parcel delivery. The company has also developed an ADS-B transponder for drones, an essential link in the identification of drones in the airspace.
AD-VENTA (France) http://www.ad-venta.com/fr/
AD-VENTA specializes in on-board gaseous hydrogen systems (H2 Pressure and Flow Rate Regulation). With in-house factory design and realization, the compact, safe and accurate turnkey solutions proposed by AD-VENTA are based on a large patent portfolio and expertise in control of high pressure compressed gases. Its markets include automotive, light mobility, aerospace and naval applications. Aerial, Ground, Surface and Underwater Unmanned Vehicles powered with hydrogen fuel cells are its short-term development targets.
HES Energy Systems Pte. Ltd.
Office: (+65) 6250 3949
Direct: (+65) 9710-8445
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Outline of New ESMO Guidelines Indicates Inclusion of FOTIVDA®▼ (Tivozanib) for Patients with Advanced Renal Cell Carcinoma22.10.2018 07:51 | Pressemelding
EUSA Pharma (EUSA) welcomes the news that FOTIVDA®▼ (tivozanib) is expected to be included in the upcoming European Society of Medical Oncology (ESMO) clinical practice guidelines for advanced renal cell carcinoma (aRCC), anticipated to be published at the end of this year.1 The outline of the new proposed guidelines was presented on 19th October at the annual ESMO 2018 Congress in Munich, Germany, and indicated that tivozanib will be included as a first-line treatment recommendation for aRCC clear cell histology patients. The update will position tivozanib as a treatment standard for good (or favourable) risk patients with a Class IIa recommendation, and a treatment option for intermediate risk patients with a Class IIb recommendation.1 The indication of inclusion of tivozanib in the ESMO guidelines follows the grant of a European Commission (EC) licence in August 2017 for this oral, once-daily,a potent selective vascular endothelial growth factor receptor tyrosine kinase inhibitors (
Open Fiber Powers Its Optical Network With SM Optics WDM ROADM22.10.2018 07:00 | Pressemelding
Open Fiber a national wholesales operator awards SM Optics, part of SIAE MICROELETTRONICA group a contract to supply and deploy WSS-free WDM ROADM technology extending fibre connectivity from their fibre backbone to metro/regional sites. The new network transports the FTTH (fibre-to-the-home) and FWA (Fixed-wireless-access) aggregated traffic, delivering ultra-broadband service to houses and local businesses. Open Fiber mission is to build a nationwide fiber network, bringing fibre connectivity to the vast majority of households and enterprises in the country, with a target of almost 19 million property units. This optical access infrastructure will enable operators delivering next generation services from FTTH broadband network for data, gaming, video streaming and mobile connectivity to 5G and IoT. SM Optics optical transport solution offers unprecedented flexibility in the smallest footprint, successfully meeting the challenge of limited space deployment and low power consumption. F
Zscaler Extends Cloud DLP Service with Inline Exact Data Match for Massive Data Sets Covering Users Globally22.10.2018 06:30 | Pressemelding
Zenith Live Europe – Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced inline Exact Data Match (EDM) with native SSL inspection as part of its advanced Cloud Data Loss Prevention (DLP) service. The inline EDM capability extends the Zscaler™ cloud platform to protect against the loss of sensitive information across all users and branches with more precision while reducing the number of false positives to near zero. This service is provided in the Zscaler cloud, providing the capacity of one billion data points per customer across 100 data centers globally. Traditional DLP appliances that sit in the data center are expensive and resource-intensive, and their protection can be subpar, often failing to alert an organization until after data has been compromised. Zscaler’s inline EDM with native SSL inspection blocks sensitive information before it leaves the network. In the first half of 2018, the Zscaler cloud platform blocked an average of 800,000 SSL-encrypted tr
Vivior Chairman Receives Award for Outstanding Contributions to Refractive Surgery22.10.2018 06:00 | Pressemelding
Michael Mrochen, PhD, Chairman of the Board of Directors at Vivior, receives the Casebeer Award from the International Society of Refractive Surgery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181021005012/en/ Michael Mrochen, PhD Chairman of the Board of Directors Vivior AG (Photo: Business Wire) The International Society of Refractive Surgery (ISRS), a partner of the American Academy of Ophthalmology, is the leading worldwide organization for refractive surgeons. Each year, ISRS awards members for their special contributions to the ISRS, as well as their dedication to the field. The Casebeer Award recognizes an individual for his or her outstanding contributions to refractive surgery through nontraditional research and development activities (https://www.isrs.org/about-isrs/awards). Michael Mrochen is internationally known for his pioneering work on corneal laser surgery, corneal cross linking, ocular biometry and corn
Investigational Subcutaneous Formulation of Vedolizumab Achieves and Maintains Clinical Remission and Mucosal Healing at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis22.10.2018 05:00 | Pressemelding
Takeda Pharmaceutical Company Limited [TSE:4502] (“Takeda”) today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous (SC) formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis (UC) who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous (IV) induction therapy. At week 52, a statistically significant proportion of patients receiving vedolizumab SC achieved clinical remission** compared to patients receiving placebo (46.2% vs. 14.3%; p<0.001). A similar rate of clinical remission was observed in the vedolizumab IV reference arm (42.6%). These results were presented at the 2018 United European Gastroenterology (UEG) Week congress in Vienna, Austria. “The VISIBLE 1 results highlight that the investigational subcutaneous formulation of vedolizumab helped patients with moderat
Incyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Selective FGFR Inhibitor, in Patients with Cholangiocarcinoma21.10.2018 10:45 | Pressemelding
Incyte Corporation (Nasdaq:INCY) announces updated data from its ongoing Phase 2 FIGHT-202 trial evaluating pemigatinib (INCB54828), its selective fibroblast growth factor receptor (FGFR) inhibitor, in patients with advanced/metastatic or surgically unresectable cholangiocarcinoma (bile duct cancer) who failed at least one previous treatment. In patients with FGFR2 translocations who were followed for at least eight months, interim study results demonstrated an overall response rate (ORR) of 40 percent, the primary endpoint, and a median progression free survival (PFS) of 9.2 months, a key secondary endpoint. These results are being presented at the European Society for Medical Oncology (ESMO) 2018 Congress in Munich, Germany in a poster presentation on Sunday, October 21 from 12:45 p.m. CEST to 1:45 p.m. CEST (6:45 a.m. ET to 7:45 a.m. ET). (Location: Hall A3 – Poster Area Networking Hub; Abstract #756P) “We are pleased to share updated interim results from our ongoing FIGHT-202 trial